Avacta Group (LON:AVCT) Stock Passes Above 50 Day Moving Average – Here’s Why

Avacta Group Plc (LON:AVCTGet Free Report) crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 64.94 and traded as high as GBX 78. Avacta Group shares last traded at GBX 74, with a volume of 3,348,313 shares trading hands.

Avacta Group Stock Performance

The business’s 50-day moving average is GBX 64.94 and its two-hundred day moving average is GBX 66.01. The company has a current ratio of 0.79, a quick ratio of 4.96 and a debt-to-equity ratio of 14,168.75. The stock has a market capitalization of Ā£335.59 million, a PE ratio of -4.22 and a beta of 1.12.

Avacta Group Company Profile

(Get Free Report)

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISIONĀ® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).

Read More

Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.